FDCDDQ
DERM icon

Federation des caisses Desjardins du Quebec’s Journey Medical DERM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-300
Closed -$2.31K – 2993
2025
Q4 		$2.31K Hold
300
– – ﹤0.01% 2582
2025
Q3 		$2.14K Hold
300
– – ﹤0.01% 2587
2025
Q2 		$2.15K Hold
300
– – ﹤0.01% 2399
2025
Q1 		$1.77K Hold
300
– – ﹤0.01% 2346
2024
Q4 		$1.17K Hold
300
– – ﹤0.01% 2303
2024
Q3 		$1.7K Hold
300
– – ﹤0.01% 2246
2024
Q2 		$1.69K Buy
+300
New +$1.23K ﹤0.01% 2126

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's DERM Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 300 shares — an estimated $2.31K sold.

Federation des caisses Desjardins du Quebec first reported a position in DERM in Q2 2024 and held it in 7 quarters. The position peaked at $2.31K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Federation des caisses Desjardins du Quebec reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 300 Journey Medical shares in Q1 2026, an estimated $2.31K.
  • Federation des caisses Desjardins du Quebec first reported a position in Journey Medical in Q2 2024 and held it in 7 quarters.
  • Federation des caisses Desjardins du Quebec's Journey Medical position peaked at $2.31K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.